JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2576
Assembly Biosciences
ASMB
$452M
| $3.43M | ﹤0.01% |
+13,825
| New | +$3.89M |
2017 Q2
0 quarters
|
|
|
HI
2577
DELISTED
Hillenbrand
HI
| $3.41M | ﹤0.01% |
94,571
+13,256
| +16% | +$483K |
2015 Q4
6 quarters
|
|
2578
CALL
AstraZeneca
AZN
$246B
| $3.41M | ﹤0.01% |
+50,000
| New | +$3.27M |
2017 Q2
0 quarters
|
|
2579
Fluor
FLR
$6.95B
| $3.41M | ﹤0.01% |
74,405
-358,282
| -83% | -$17.1M |
2013 Q2
16 quarters
|
|
|
TGI
2580
DELISTED
Triumph Group
TGI
| $3.39M | ﹤0.01% |
107,436
+103,533
| +2,653% | +$2.88M |
2013 Q2
16 quarters
|
|
2581
iShares MSCI South Africa ETF
EZA
$465M
| $3.39M | ﹤0.01% |
59,687
+54,505
| +1,052% | +$3.18M |
2013 Q2
16 quarters
|
|
|
FLXN
2582
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.38M | ﹤0.01% |
167,350
+52,763
| +46% | +$1.1M |
2015 Q4
6 quarters
|
|
|
JUNO
2583
DELISTED
Juno Therapeutics, Inc.
JUNO
| $3.38M | ﹤0.01% |
113,124
+50,378
| +80% | +$1.24M |
2014 Q4
10 quarters
|
|
2584
Federal Agricultural Mortgage
AGM
$2.32B
| $3.36M | ﹤0.01% |
51,932
-4,961
| -9% | -$300K |
2016 Q1
5 quarters
|
|
2585
Sierra Bancorp
BSRR
$512M
| $3.36M | ﹤0.01% |
136,800
+16,996
| +14% | +$432K |
2013 Q2
16 quarters
|
|
2586
CALL
Ford
F
$49B
| $3.36M | ﹤0.01% |
300,000
-180,100
| -38% | -$2.01M |
2015 Q3
7 quarters
|
|
|
RSO
2587
DELISTED
Resource Capital Corp.
RSO
| $3.35M | ﹤0.01% |
329,150
-9,740
| -3% | -$93.7K |
2013 Q2
16 quarters
|
|
|
GOOD
2588
Gladstone Commercial Corp
GOOD
$615M
| $3.35M | ﹤0.01% |
153,600
+5,075
| +3% | +$108K |
2013 Q3
15 quarters
|
|
2589
Exponent
EXPO
$3.29B
| $3.34M | ﹤0.01% |
114,710
-1,600
| -1% | -$47.8K |
2013 Q2
16 quarters
|
|
|
OCLR
2590
DELISTED
Oclaro Inc.
OCLR
| $3.33M | ﹤0.01% |
356,378
-94,684
| -21% | -$857K |
2016 Q3
3 quarters
|
|
2591
The Ensign Group
ENSG
$10B
| $3.31M | ﹤0.01% |
162,601
-93,748
| -37% | -$1.71M |
2013 Q2
16 quarters
|
|
2592
Cemex
CX
$14.3B
| $3.31M | ﹤0.01% |
351,040
+170,907
| +95% | +$1.51M |
2013 Q2
16 quarters
|
|
2593
Tractor Supply
TSCO
$16.8B
| $3.31M | ﹤0.01% |
305,105
-350,550
| -53% | -$4.17M |
2013 Q2
16 quarters
|
|
2594
Vanguard Emerging Markets Government Bond ETF
VWOB
$6.12B
| $3.31M | ﹤0.01% |
41,263
+8,887
| +27% | +$713K |
2015 Q4
6 quarters
|
|
2595
FIVE9
FIVN
$2.49B
| $3.3M | ﹤0.01% |
153,418
-25,838
| -14% | -$529K |
2015 Q2
8 quarters
|
|
2596
Southern Copper
SCCO
$172B
| $3.3M | ﹤0.01% |
104,035
-14,528
| -12% | -$466K |
2013 Q2
16 quarters
|
|
2597
Scholastic
SCHL
$681M
| $3.29M | ﹤0.01% |
75,494
-9,632
| -11% | -$416K |
2015 Q3
7 quarters
|
|
|
NSA
2598
DELISTED
National Storage Affiliates Trust
NSA
| $3.29M | ﹤0.01% |
142,227
-22,406
| -14% | -$537K |
2015 Q3
7 quarters
|
|
2599
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.63B
| $3.27M | ﹤0.01% |
59,104
-56,593
| -49% | -$3.11M |
2013 Q2
16 quarters
|
|
2600
Advance Auto Parts
AAP
$2.49B
| $3.27M | ﹤0.01% |
28,034
-2,880
| -9% | -$395K |
2013 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.